For more than 50 years, Vedder has counseled and advocated on behalf of a broad spectrum of health care organizations and life sciences companies, including their lenders and investors.
You can expect a team of highly experienced, responsive attorneys who understand your market, your issues, and the evolving matters facing health care and life sciences businesses today.
Health Care
Broad health care credentials. Our clients include:
- Major health care provider institutions and health systems
- Health care lenders
- Physician organizations
- Managed-care organizations
- Individual and group health care practitioners and practices
- Professional membership associations
- Not-for-profit organizations and foundations
- Health care staffing companies
- Ambulatory surgery centers
- Diagnostic imaging centers
- Dialysis centers
- Practice management companies
Life Sciences
Deep regulatory experience. Our clients include growth and mature companies in FDA-regulated industries:
- Pharmaceuticals, Biologics & Compounding
- Medical Devices, Diagnostics, Digital Health & Radiation-Emitting Technologies
- Food, Beverage, Dietary Supplements & Consumer Health
- Cosmetics, Personal Care & Aesthetic Wellness
- Tobacco, Nicotine & Alternative Products
- Veterinary & Agricultural Sciences
Insights & Events
Publications
Wisconsin’s Loon Enforcement Action Underscores the Importance of State Nicotine Directories
August 27, 2026
Publications
Lilly’s Retatrutide Lawsuits Spotlight Expanding Enforcement Risk for the Peptide and GLP-1 Industry
August 26, 2026
Publications
FDA Nicotine Regulation in 2026: PMTAs, Enforcement Discretion, and State Sales Restrictions
August 20, 2026
Publications
Beyond Hims & Hers: What the FTC’s Latest Consumer Protection Action Means for Online DTC Businesses
August 7, 2026
Publications
After the Peptide Vote: Why FDA’s PCAC Recommendations Could Mark an Inflection Point for Peptide Compounding
August 6, 2026
Blogs / Publications
DOJ Announces First Health Care Resolution Under New Corporate Enforcement and Voluntary Self-Disclosure Policy
August 3, 2026
News
Vedder Adds Depth to Washington, DC Office With Addition of Life Sciences Attorney Melissa Gilmore
June 1, 2026
Blogs
“Skyrocketing” Medicare Part B Claims Submissions on Skin Substitutes
October 31, 2025